AllDocs -> cancers

Cancer Mortality by Socioeconomic Status in Queensland Cancer of Kidney And Other Renal Tract 0 3 6 9 12 15 0 3 6 9 12 15 Male Female Rate per 100,000 population Rate per 100,000 population Avg No. Avg No. per Year per Year Mortality of Cancer of Kidney And Other Renal Tract, by SEIFA category and Sex, Queensland, Five Year Average, 1998 to 2002 6.4 12 3.2 8 High SES SEIFA Quintile 5.7 17 3.2 11 Mod. high SES 5.5 17 3.8 13 Moderate SES 6.5 26 4.0 20 Mod. Low SES 6.1 19 4.2 16 Low SES Note: Rates are age standardised to the Australian population as at 30 June 2001. ...

RESULTS OF XCYTE THERAPIES' XCELLERATED T CELLS IN ADVANCED KIDNEY CANCER REPORTED IN CLINICAL CANCER RESEARCH Seattle, WA-September 25, 2003 - Xcyte Therapies, Inc. announced today that results from a Phase I clinical trial of its proprietary Xcellerate Technology for the treatment of patients with advanced kidney cancer were published in the September 1, 2003 issue of the journal, Clinical Cancer Research. The study is entitled "A Phase I Trial Of CD3/CD28-activated T Cells (Xcellerated T Cells) and Interleukin-2 in Patients with Metastatic Renal Cell Carcinoma." In the study, 25 patients with metastatic kidney cancer were treated with two infusions of Xcellerated T Cells approximately four weeks apart. After each infusion of Xcellerated T Cells, patients were treated with low doses of interleukin-2 for ten consecutive days. There were no serious adverse effects related to the administration ...

removal of a perirenal fibrolipoma. Partial nephrecto- my to treat renal malignancy was first described in 1890 by Czerny. 2 In 1950,Vermooten 3 reported that peripherally located, encapsulated renal tumors could be removed by partial excision of renal tissue. Partial nephrectomy has now become a standard procedure for appropriately selected patients with renal cell car- cinoma (RCC). Indications Nephron-sparing surgery is indicated for cases in which a radical nephrectomy would render the patient anephric with a subsequent immediate need for dialy- Current Status of Partial Nephrectomy in the Management of Kidney Cancer Arndt van Ophoven, MD, Ke-Hung Tsui, MD, Oleg Shvarts, Sherelle Laifer-Narin, MD, and Arie S.Belldegrun, MD Background: The technique of partial nephrectomy for managing renal cancers is well recognized, but ...

Kidney Cancer Association Targets Research Henk Verheul, M.D., Ph.D. receives 2006 Young Investigator Award. Chicago, IL (PRWEB) March 23, 2006 -- The Kidney Cancer Association (KCA) today announced the selection of Henk Verheul, M.D., Ph.D. as recipient of the 2006 ASCO Young Investigator Award funded by a grant from the KCA. "The KCA is taking action to cure kidney cancer by continuing our expansion of collaboration on research projects," said KCA president Bill Bro. "In addition to Dr. Verheul's important work, we're also currently involved with three statistical research projects, including that of our international staging group," Bro added. "Two of these projects encourage the direct participation of patients. This gives families an opportunity to do something that will benefit others whose lives are touched by this dreadful disease. Anyone who would like to be a part of these projects can call ...

Action to Cure Kidney Cancer Awards $45,000 Grant to Fox Chase Cancer Center Researcher Action to Cure Kidney Cancer awards a $45,000 grant to Paul Cairns, Ph.D., a member of the medical science division of Fox Chase Cancer Center, to purchase a state-of-the-art DNA enhancing machine to assist his work in developing a urine screening test that will detect early stage kidney cancer . New York, NY (PRWEB) March 20, 2006 -- Action to Cure Kidney Cancer (ACKC) awards $45,000 to Paul Cairns to purchase a real-time PCR (Polymerase Chain Reaction) system that will expedite his work in the development of a urine-screening test for early stage kidney cancer as well as his research in the monitoring of treatment for the disease. This technology will enable Dr. Cairns to identify one cancer cell in 10,000 normal cells, a tenfold increase in accuracy over previous technology. Kidney ...

Kidney Cancer Page 2 2 Each year, 36,000 Americans are diagnosed with kidney cancer . The vast majority of these patients suffer from renal cell carcinoma, a malignancy in the tissue cells where blood is filtered into urine. Most kidney cancers are primary tumors meaning they originate in the kidney rather than spreading from other areas of the body. They can still be deadly if not found early and treated aggressively. Fortunately, urologists—doctors who specialize in diseases of the male and female urinary tracts and the male reproductive system—have effective ways today to diagnose and treat kidney cancer , especially if it is caught early. Imaging tests that involve little or no discomfort for patients allow physicians to pinpoint these malignancies with accuracy, efficiency and relative speed. Similarly, ...

European Kidney Cancer Symposium Sponsor : Kidney Cancer Association Friday, April 28 ,2006 Biology , Genetics and prognostic factors of RCC : 13:00 Genetics of Renal Cell Carcinoma Inherited Syndromes 13:30 Renal Cell Carcinoma : Pathologic Classification and Features 14:00 Staging Systems : Localized RCC 14:15 Prognostic Factors : Advanced & Metastatic RCC 14:30 Discussion 15:00 Break 15:30 Novel imaging techniques in RCC 15:45 Doppler Ultrasound Surgical Treatment : Renal Cell Carcinoma 16:00 Partial Nephrectomy Andrew Novick, Cleveland, OH 1620 Laparoscopic Nephrectomy : indications & role 16:40 Nonsurgical Ablative Techniques 17:00 Panel Discussion 18: 00 Welcome reception Saturday, April 29, 2006 Systemic therapies for RCC Overviews 8:00 Current Therapeutic Options for Advanced/Metastatic ...

of the file http://tricare.osd.mil/eenews/downloads/122105%20FDA%20OKs%20Oral%20Kidney%20Cancer%20Treatment.doc . G o o g l e automatically generates html versions of documents as we crawl the web. To link to or bookmark this page, use the following url: http://www.google.com/search?q=cache:il6lGOnGhIMJ:tricare.osd.mil/eenews/downloads/122105%2520FDA%2520OKs%2520Oral%2520Kidney%2520Cancer%2520Treatment.doc+allintitle:+kidney+cancer+filetype:pdf+OR++filetype:doc+OR+filetype:ppt+OR++filetype:xls+OR+filetype:rtf&hl=it&ct=clnk&cd=79&lr=lang_en Google is neither affiliated with the authors of this page nor responsible for its content. These search terms have been highlighted: kidney cancer 1146 FDA OKs Oral Kidney Cancer Treatment By JOHN J. LUMPKIN The Washington Post The Associated Press Wednesday, December 21, 2005; 6:05 AM WASHINGTON ...

LS/renal/1/00 George Eliot Hospital NHS Trust Department of Urology Kidney Cancer This is a malignant tumour of the kidney . It consists of cells that are no longer under normal control and have acquired the ability to grow uncontrollably and to spread beyond the site of origin into nearby organs(local spread) or distant organs (metastasis). There are several types of cancer of the kidney , but the commonest is renal cell cancer . This usually occurs in middle aged and older people. The kidneys are paired organs in the back of the abdomen that filter the blood to remove waste products which are excreted in the urine. Urine passes from the kidneys to the bladder for storage till a convenient time for voiding. Symptoms Blood in urine. There may occasionally be blood clots. Lump in the abdomen. Pain in the kidney area. Weight loss in advanced cases. Diagnosis ...

RISK FACTOR INFORMATION FOR SELECTED CANCER TYPES Source: Community Assessment Program, Center for Environmental Health, Massachusetts Department of Public Health. March, 2005 201 Kidney cancer Kidney cancer involves a number of tumor types located in various areas of the kidney and renal system. Renal cell cancer (which affects the main area of the kidney ) accounts for over 90% of all malignant kidney tumors (ACS, 2001). The American Cancer Society estimates that there will be approximately 36,160 cases of kidney and upper urinary tract cancer , resulting in more than 12,660 deaths in 2005 (ACS, 2004). The incidence and mortality from kidney cancer is higher in urban areas, which may be due to increased access to diagnostic services and other factors such as smoking. Kidney cancer is twice as common in males as it is in females and the incidence most often occurs in the fifth ...

Trends in Cancer Mortality by Health Zone in Queensland Cancer of Kidney And Other Renal Tract Rate per 100,000 population Mortality of Cancer of Kidney And Other Renal Tract, by Health Zone, Queensland, 1986 to 2002 Northern Central Southern 0 3 6 9 12 15 Year 1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 Note: Rates are age standardised to the Australian population as at 30 June 2001. Data are reported by place of usual residence and year of diagnosis. Cancer of Kidney And Other Renal Tract is defined by the ICD-0-2 codes of C64 to C66 and C68 Source: Queensland Cancer Registry, Queensland Health and Queensland Cancer Fund. Generated by Epidemiology Services Unit, Queensland Health ...

KIDNEY CANCER H fa k b v E b ^ iqe > r p qo ^ if^ m ^ d b . , . WHAT IS KIDNEY CANCER ? Q e b ob ^ ob p b s b o ^ i qv m b p l c h fa k b v `^ k `b o+ Q e b j l p q `l j j l k fp O b k ^ i @ b ii @ ^ o`fk l j ^ + L qe b o qv m b p l c h fa k b v `^ k `b o p fk `ir a b 7 ñ Q o^ k p fqfl k ^ i `b ii `^ o`fk l j ^ p * ^ o fp fk d fk qe b `l iib `qfk d p v p qb j l c qe b h fa k b v ñ T fij p $ qr j l r o * ^ qr j l r o l ``r o ofk d fk `e fia ob k ñ O b k ^ i p ^ o`l j ^ * ^ o ^ ob cl o j l c h fa k b v `^ k `b o ñ O b k ^ i ^ a b k l j ^ p * p j ^ ii il t *d o^ a b qr j l r op ñ L k `l `v ql j ^ p ^ k a > k d fl j v l ifm l j ^ p * _ b k fd k qr j l r op l c qe b h fa k b v > p t fqe ^ ii `^ k `b op ) h fa k b v `^ k `b op _ b d fk p j ^ ii ^ k a d o l t i^ o d b o l s b o qfj b + H fa k b v `^ ...

82.00 EVALUATION OF KIDNEY FUNCTION OF LONG-TERM CHILDHOOD CANCER SURVIVORS E. Bardi , I. Bobok, A.V. Olah, C. Kiss University of Debrecen, Health and Science Center, Debrecen, Hungary editbardi@hotmail.com We investigated renal function of 99 pediatric long-term survivors of leukemia and solid tumors treated according to standard protocols. Glomerular filtration rate (GFR) was assessed with the cystatin C method. Proximal tubular function was characterized by urinary ?-Nag-ase enzyme activity and microalbuminuria. Distal tubular function was determined by serum/urine osmolarity. We performed genomic PCR to determine a possible influence of I/D polimorphism of the angiotensin convertase (ACE) gene on late nephrotoxicity. Endogenous antioxidant level, was determined according to beef-brain autooxidation method. Kidney function of patients was compared to that of 86 age- and sex-matched ...

How Competition Can Compromise the Cause for Kidney Cancer Patients Guest editorial in Kidney Cancer Journal co-authored by leading oncologist calls for unity among cancer advocates. (PRWEB) February 15, 2006 -- The current issue of Kidney Cancer Journal features a guest editorial co-authored by Janice P. Dutcher, MD, Associate Director for Clinical Affairs, Our Lady of Mercy Comprehensive Cancer Center, Bronx, New York, and Professor of Medicine New York Medical College, Valhalla, New York. Dr. Dutcher, one of the nation's leading kidney cancer researchers, along with William P. Bro, CEO of the Chicago-based Kidney Cancer Association (KCA), call for unity among cancer advocates. The editorial explains that some disease advocates have begun lobbying the federal government to earmark funds specifically for kidney cancer . However, this approach is not only contrary to the KCA’s position, ...

Kidney Cancer Association March on Capitol Hill KCA helps federal legislators to better understand how kidney cancer affects the lives of thousands of Americans (PRWEB) February 20, 2006 -- The Kidney Cancer Association (KCA) recently sponsored a well-received educational briefing for members of the Congressional Kidney Caucus. More than 40 Congressional offices sent staff to the briefing. In addition to the Hill staffers, representatives from the FDA and the National Kidney Foundation were present. Congressman Kirk's staffer, Jeff Phillips, was on hand to give the opening to the briefing. The bipartisan Congressional Kidney Caucus was founded by Representatives Jim McDermott (D-WA) and Mark Kirk (R-IL) in March, 2002. The purpose of the Caucus is to educate Members of Congress and the public about the problem kidney disease poses for our society. Lobby Day 2006 KCA supporters can ...

Kidney Cancer Association (KCA) Targets Young Investigators The Kidney Cancer Association (KCA) announces a $40,000 grant to fund a young investigator award through ASCO Foundation of the American Society of Clinical Oncology (PRWEB) September 4, 2005 -- The Kidney Cancer Association (KCA) today made a $40,000 contribution to fund a young investigator award through the ASCO Foundation. In announcing KCA's grant to the foundation, CEO Bill Bro said, "We are pleased to make this award through the ASCO Foundation of the American Society of Clinical Oncology, because of the mutual interest of our organizations in funding the work of young investigators. If we are to conquer cancer in our lifetime, it requires a long-term commitment to attracting talented researchers." "ASCO has ability to enlist the help of international, high-profile thought leaders in every cancer subspecialty, and the wherewithal ...

A214: Kidney and ureter cancer tissues For research use only (formalin fixed) Specifications: • No. of cases: 31 • Tissue type: Kidney and ureter cancer tissues ( kidney :28, ureter:3) • No. of spots: 2 spots from each cancer case (62 spots) 6 non-neoplastic spots (6 spots) • Total spots: 68 • Corresponding normal tissues with cancers: Yes • Diameter: 1. 0 mm Documents : • Product specification: layout, summary of tissue spots • H&E stained images • Detailed pathological information Layout: Page 2 A214: Kidney and ureter cancer tissues For research use only (formalin fixed) Summary of tissue spots No. Sex Age Key Word Grade TNM Stage 1 1,2 M 45 RCC.conventional type 1 T1aN0M0 (I) 2 3,4 ...

Web Immagini Gruppi Directory News altro » Ricerca avanzata Preferenze Cerca nel Web Cerca solo le pagine in Inglese Spiacenti, nessun contenuto associato a questo URL Web La ricerca di - cache:7cqE9gvSb1cJ:www.curekidneycancer.org/files/KSP%20Notes%20from%20IKCSIV%20Oct%2005%20Final.pdf allintitle: kidney cancer filetype:pdf OR filetype:doc OR filetype:ppt OR filetype:xls OR filetype:rtf - non ha prodotto risultati in nessun documento. Suggerimenti: Assicurarsi che tutte le parole siano state digitate correttamente. Provare con parole chiave diverse. Provare con parole chiave più generiche. Provare ...

Kidney (Renal Cell) Cancer Overview © copyright 2006 U-M Comprehensive Cancer Center The University of Michigan Health System web site does not provide specific medical advice and does not endorse any medical or professional service obtained through information provided on this site or any links to this site. Use of the UMHS web site does not replace medical consultation with a qualified health or medical professional to meet the health and medical needs of you or others. While the content of the UMHS web site is frequently updated, medical information changes rapidly and therefore, some information may be out of date, and/or contain inaccuracies or typographical errors . Renal cell cancer (or renal cell carcinoma) is the most common type of kidney cancer . It is a life-threatening tumor, which is an abnormal growth of cells. Your kidneys are located on each side of your spine ...

Web Immagini Gruppi Directory News altro » Ricerca avanzata Preferenze Cerca nel Web Cerca solo le pagine in Inglese Spiacenti, nessun contenuto associato a questo URL Web La ricerca di - cache:RNznBvb_7IEJ:www.bccancer.bc.ca/NR/rdonlyres/A11E4122-9FC3-498A-BC34-B9693BD0A607/2059/Tab122.pdf allintitle: kidney cancer filetype:pdf OR filetype:doc OR filetype:ppt OR filetype:xls OR filetype:rtf - non ha prodotto risultati in nessun documento. Suggerimenti: Assicurarsi che tutte le parole siano state digitate correttamente. Provare con parole chiave diverse. Provare con parole chiave più generiche. ...

14 x Worst Pills, Best Pills News Kidney -toxic And Cancer -causing Chinese Herbal Supplements Are Recalled E ast Earth Herb, Inc. of Eugene, Oregon issued a recall on November 21, 2000, of its Jade Pharmacy brand Meridian Circulation tablets and liquid extract and Jade Pharmacy brand Quell Fire tablets because they present a serious health hazard to consumers. The prod- ucts contain aristolochic acid, a potent cancer -causing and kidney - toxic agent found in certain plants and botanicals. About 600 species of the plant family Aristolochiacea contain this chemical. Meridian Circulation and Quell Fire were distributed throughout the U.S. through a variety of complementary-alternative-medi- cine proponents. A list of the recalled products and their lot numbers appears on this page. We reported in the July 2000 ...

Web Immagini Gruppi Directory News altro » Ricerca avanzata Preferenze Cerca nel Web Cerca solo le pagine in Inglese Spiacenti, nessun contenuto associato a questo URL Web La ricerca di - cache:zIYjGhZ0LcUJ:healthsci.otago.ac.nz/dsm/preventivemed/esrd/reports/Study_desc_2.pdf allintitle: kidney cancer filetype:pdf OR filetype:doc OR filetype:ppt OR filetype:xls OR filetype:rtf - non ha prodotto risultati in nessun documento. Suggerimenti: Assicurarsi che tutte le parole siano state digitate correttamente. Provare con parole chiave diverse. Provare con parole chiave più generiche. Provare con un ...

a report by Vincent Launay-Vacher and Gilbert Deray Nephrology Clinical Pharmacist, and Professor of Nephrology, Assistant Physician and Head, Department of Nephrology, Pitié-Salpêtrière Hospital Ca ncer pa tients receiving chemotherapy for their disease are at risk of developing renal toxicity. Indeed, they often present with several risk factors, such as dehydration or old age, that may favour anticancer drugs nephrotoxicity. Furthermore, in a recently published pilot study performed on 316 ca ncer pa tients in France, abnormal renal function – according to Cockcroft-Gault creatinine clearance (CG CRCL) – below 80ml/min was observed in 33% of the patients, whatever the disease, its stage or the treatment received. 1 In a larger study, including nearly 5,000 French ca ncer pa tients from 14 oncology centres, the preliminary results ...